| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fefeab75b3920adcec0784424c5392b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_314407688f3e01aaacd82b2ee3112d4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff198ba500c81e46813a5ab6f8ca539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f861d7dfdde7b233339d4838364a8e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 |
| filingDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_271e82511420df249ffcc9012bf45e8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d0eb91ba112e6f89b684550d47b16ee |
| publicationDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03039435-A2 |
| titleOfInvention |
Process of obtaining colloidal dispersions of amphotercin b; compounds based on amphothericine b for enteral, paraenteral and topical use; use of these compounds in the treatment of systemic mycoses and parasitic infections |
| abstract |
The present invention has as its objective the process of obtaining of compositions containing amphotericin B in its superaggregate from capable of treating infections caused by fungi, parasites and other agents susceptible to this antibiotic. The invention covers the stable formulation of amphotericin B in its superaggregate form in presence of sodium deoxycholate, freeze-dried (lyophilized) and sterile, uniting the requirements for an injectable formulation for use enteral, parenteral or topical, with reduced toxicity in comparison to the conventional forms that transmit amphotericin B. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005203908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005065712-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005065712-A3 |
| priorityDate |
2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |